Koninklijke Philips (0A2M) Price & Analysis
0A2M Stock Chart & Stats
- Day’s Range
- $27.03 - $27.09
- 52-Week Range
- $23.71 - $33.40
- Previous Close
- $27.10
- Volume
- 16.59K
- Average Volume (3M)
- 3,205
- Market Cap
- $26.40B
- Enterprise Value
- $32.86B
- Total Cash (Recent Filing)
- $1.79B
- Total Debt (Recent Filing)
- $7.46B
- Price to Earnings (P/E)
- 20.7
- Beta
- 1.39
- Next Earnings
- Nov 03, 2026
- EPS Estimate
- 0.39
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 3.65%
Bulls Say, Bears Say
Bulls Say
Record Order Book And Resilient Demand
Resilient orders and a record equipment backlog provide visibility into future equipment revenue and support utilization of Philips’ service ecosystem. This strengthens planning and investment capacity over the next several quarters, although conversion timing can vary by project.
Personal Health Growth And Product Innovation
Personal Health is showing strong growth alongside favorable product mix and market-share gains, giving Philips a profitable consumer-health contributor alongside hospital businesses. Continued launches can reinforce brand strength and diversify the company’s revenue base.
Productivity Gains And Improving Leverage
Productivity execution is generating tangible savings while lower leverage improves financial resilience and investment flexibility. If sustained, these gains can help offset inflation, support margins, and strengthen Philips’ ability to fund innovation and customer programs.
Bears Say
Volatile Profitability And Cash Conversion
The return to profit and positive cash generation has not yet established a consistent earnings pattern. Prior losses and declining free cash flow indicate that operating performance and cash conversion remain vulnerable, limiting confidence in the durability of the recovery.
China Procurement And Inflation Pressure Margins
China’s procurement dynamics can reduce pricing power in health systems, while elevated input costs pressure gross and operating margins. Together, these forces may require continued productivity actions and create a durable execution burden across affected businesses.
Unresolved Respironics Legal And Regulatory Exposure
Unresolved legal and regulatory proceedings create an ongoing source of uncertainty beyond Philips’ operating plan. Potential effects on future results, management attention, and financial flexibility make the recovery less predictable until these matters are resolved.
Koninklijke Philips News
0A2M FAQ
What was Koninklijke Philips’s price range in the past 12 months?
What is Koninklijke Philips’s market cap?
When is Koninklijke Philips’s upcoming earnings report date?
How were Koninklijke Philips’s earnings last quarter?
Is Koninklijke Philips overvalued?
Does Koninklijke Philips pay dividends?
What is Koninklijke Philips’s EPS estimate?
How many shares outstanding does Koninklijke Philips have?
What happened to Koninklijke Philips’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Koninklijke Philips?
What is the TipRanks Smart Score and how is it calculated?
Koninklijke Philips Stock Smart Score
Company Description
Koninklijke Philips
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Roy W. O. Jakobs
- Employees
- 66,401
- Website
- www.philips.ca
- Address
- Philips Center, Amsterdam, NH, 1077 WV, NL
Koninklijke Philips (0A2M) Earnings & Revenues
0A2M Company Deck
0A2M Earnings Call
Earnings Call SentimentPositive
The call conveyed a generally positive operational and financial tone: key growth metrics (comparable sales ~4%), strong order momentum (rolling 12‑month +5%), record equipment order book, robust Personal Health performance, notable commercial wins and continued productivity delivery supported the narrative. However, meaningful near‑term headwinds remain — elevated cost inflation, China centralized procurement pressure, D&T margin weakness ex‑refund, and timing/phasing of large cloud/platform deals — some of which depress near‑term underlying margins and introduce execution risk for the back‑loaded margin recovery. On balance, the positives (growth, order book, productivity progress, balance‑sheet improvement and reiterated guidance) outweigh the lowlights, but management highlighted areas requiring continued execution.
View all GB:0A2M earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 3 | 4 |
| Technical Analysis | 3 | 3 | 4 |
| Moving Averages | 12 | 0 | 0 |